2200 PENNSYLVANIA AVE NW, WASHINGTON, DC
Market cap: $398.9M (12/18/2025)
Price: $6.75
FDA Lifts Partial Clinical Hold on Tradipitant for Motion Sickness
Provides Regulatory Update on Tradipitant for Motion Sickness
Reports Third Quarter 2025 Financial Results
Reports Second Quarter 2025 Financial Results
Shareholder votes
Earnings Release
Annual Report to Security Holders
Reg. FD
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Amended Registration of Securities
Registration of Securities
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload
Confidential Treatment Order